Interviews

Diversity Interview Series: Maria Palasis, Ph.D., President and Chief Executive Officer of Lyra Therapeutics

Diversity Interview Series: Jacqueline Kosecoff, Ph.D., Managing Partner of Moriah Partners

Diversity Interview Series: Christine Vanderpool, Chief Information Security Officer of Florida Crystals

Diversity Interview Series: Travis McCready, Former CEO Of Massachusetts Life Sciences Center

Slone Partners Exclusive Interview with Coco Brown, Founder & CEO of The Athena Alliance

Celebrating Slone Partners’ 20th Anniversary: An Interview with Adam Slone, Founder of Slone Partners

Slone Partners Exclusive Interview with Craig Overpeck, CEO of Science and Medicine Group

PMC Series: Interview with Dr. Carl June, Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies, Perelman School of Medicine at University of Pennsylvania

PMC Series: Interview with Anne-Marie Martin, Ph.D., SVP and Global Head of Precision Medicine at Novartis Pharmaceuticals Corporation

PMC Series: Interview with Kenna R. Shaw, Ph.D., Executive Director of Khalifa Institute for Personalized Cancer Therapy and Cancer Genomics Laboratory, MD Anderson Cancer Center

PMC Series: Interview with Mark P. Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific

Leadership Series: Exclusive Interview with Bonnie Addario, Lung Cancer Survivor, Co-Founder and Board Chair of GO2 Foundation for Lung Cancer

Leadership Series: Exclusive Interview with David Welch, Ph.D., Director of Science and Technology of The Good Food Institute

Slone Partners is Proud to Support Frontiers in Pediatric Genomic Medicine Conference, Produced by Rady Children’s Institute for Genomic Medicine

Leadership Series: Exclusive Interview with Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix

Leadership Series: Interview with Anthony Johnson M.D., CEO of Goldfinch Bio

PMC Series: Interview with Bryce Olson, Global Strategist, Health and Life Sciences, Intel Corporation

PMC Series: Interview with Colin Hill, Chairman, CEO and Co-Founder of GNS Healthcare

PMC Series: Interview with William Dalton, Ph.D M.D., Founder and Executive Chair of M2Gen

PMC Series: Interview with David King, Chairman and CEO of LabCorp

PMC Series: Interview with Daniel O’Day, CEO of Roche Pharmaceuticals

Leadership Series: Interview with Laurie Halloran, Founder and CEO of Halloran Consulting Group

Leadership Series: Insights, Culture As A Cornerstone

Leadership Series: Interview with Harry Glorikian, Partner at New Ventures Funds and Influential Global Business Expert

Leadership Series: Interview with Kimberly Popovits, Chairman of the Board, CEO and President of Genomic Health

PMC Series: Exclusive Interview with Joydeep Goswami, PhD, MBA, President, Clinical NGS and Oncology at Thermo Fisher Scientific

PMC Series: Interview with Michael Sherman, M.D., CMO & SVP of Health Services at Harvard Pilgrim Health Care

Interview with Barbara Weber, MD, CEO of Tango Therapeutics and Venture Partner at Third Rock Ventures

Interview with Charles Mathews

Leadership Series Featuring Phyllis Whiteley, Ph.D.

Leadership Series Featuring Dr. Johannes Fruehauf

Interview with Kristine Bordenave, M.D., F.A.C.P., Lead Medical Director, Humana

Interview with Michael Pellini, M.D., Chief Executive Officer, Foundation Medicine

Interview with Amy Abernethy, M.D., Ph.D., Chief Medical Officer, Chief Scientific Officer, Senior VP, Oncology at Flatiron Health

Interview with Stephen Eck, M.D., Ph.D., Vice President, Oncology Medical Sciences, Astellas Pharma Global Development

Leadership Series Featuring Harry Glorikian, Senior Executive, Board Director, Consultant, and Investor

Leadership Series Featuring Dave Dexter, President & CEO, Sonora Quest Laboratories

Leadership Series Featuring Adam Slone, CEO of Slone Partners

Becoming CEO: Bijan Salehizadeh, Managing Director, NaviMed Capital

Becoming CEO: Mick Correll, CEO, Genospace

Becoming CEO: Andy Fish, Executive Director of AdvaMedDx